---
title: "Collegium Reports Second Quarter 2026 Financial Results and Highlights Recent Company Progress"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295104727.md"
description: "The recent acquisition of AZSTARYS® has bolstered our ADHD portfolio, leading to an extension of our long-term revenue outlook. This strategic move has significantly enhanced our offerings in the ADHD treatment space, ultimately increasing our potential for revenue growth."
datetime: "2026-08-06T11:34:54.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295104727.md)
  - [en](https://longbridge.com/en/news/295104727.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295104727.md)
---

# Collegium Reports Second Quarter 2026 Financial Results and Highlights Recent Company Progress

The recent acquisition of AZSTARYS® has bolstered our ADHD portfolio, leading to an extension of our long-term revenue outlook. This strategic move has significantly enhanced our offerings in the ADHD treatment space, ultimately increasing our potential for revenue growth.

### Related Stocks

- [COLL.US](https://longbridge.com/en/quote/COLL.US.md)

## Related News & Research

- [Collegium Pharmaceutical (COLL) Reports Earnings Tomorrow: What To Expect](https://longbridge.com/en/news/294905631.md)
- [Is Collegium Pharmaceutical (COLL) A Bargain On Its Azstarys Deal And 2026 Guidance?](https://longbridge.com/en/news/291686028.md)
- [Super savers share the strategies to keep more than 50% of their income without feeling deprived](https://longbridge.com/en/news/295386866.md)
- [Rocket Sharing says Mexedia completes purchase of 51% stake in Stantup Service](https://longbridge.com/en/news/295563109.md)
- [Tarsus to buy Alkeus in deal worth about $450 million upfront](https://longbridge.com/en/news/295097320.md)